Annexon Inc reports results for the quarter ended in March - Earnings Summary

* Annexon Inc  ANNX.OQ  reported a quarterly adjusted loss
of 21
cents​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of -52
cents.  The mean expectation of eight analysts for the quarter
was for a loss of 34 cents per share. Wall Street expected
results to range from -40 cents to -26 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Annexon Inc's reported EPS for the quarter was a loss
of 21
cents​.
    * The company reported a quarterly loss of $25.18 million.
    * Annexon Inc shares had fallen by 33.8% this quarter and
gained 4.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 25% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Annexon Inc is
$12.00 
This summary was machine generated from LSEG data May 13 at
02:13 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.34          -0.21          Beat
 Dec. 31 2023      -0.44          -0.36          Beat
 Sep. 30 2023      -0.50          -0.43          Beat
 Jun. 30 2023      -0.54          -0.47          Beat

Recent news on Annexon

See all news